CD40LG and pelvic inflammatory disease: RBC antibodies (P = 0.002), PA-IgM (P = 0.023), TGA-IgA (P = 0.021), anti-ENA antibodies (P = 0.039), and RF (P = 0.048) were significantly more frequent in PID patients when compared to healthy controls (Table 6).